Skip to main content
. Author manuscript; available in PMC: 2021 Apr 11.
Published in final edited form as: Gynecol Oncol. 2020 Aug 23;159(2):509–514. doi: 10.1016/j.ygyno.2020.08.015

Table 4.

Multivariable Model of Musculoskeletal Symptoms.

Characteristic Odds Ratio (95% CI) P-value
Age at Diagnosis, per 10 years 0.97 (0.94,1.01) 0.092
Aromatase Inhibitor 0.031
 Anastrozole vs. Exemestane 0.85 (0.76, 0.96) 0.008
 Letrozole vs. Exemestane 0.87 (0.76, 0.99) 0.036
SSRI Use – yes vs. no 0.82 (0.77, 0.89) <0.001
Gabapentin Use – yes vs. no 0.88 (0.83, 0.94) <0.001
Measurable Disease at AI Initiation – yes vs. no 0.91 (0.84, 0.99) 0.033

Odds ratio is calculated using generalized estimating equations approach after backward elimination.

SSRI = selective serotonin reuptake inhibitor; AI = aromatase inhibitor.